DiagnosticsPSMA PET/CT

Molecular imaging

PSMA PET/CT in Germany for Prostate Cancer

A source-led guide to PSMA PET/CT in Germany for prostate-cancer staging and treatment planning, including preparation and records for specialist review.

By Treat in Germany Editorial TeamSources reviewed: 2026-08-29Independent clinician review: not yet claimed
Short answer: PSMA PET/CT is a specialist imaging test used in selected prostate-cancer pathways to look for PSMA-expressing disease. It is not a general cancer screening scan. The exact indication depends on the clinical question, previous treatment, PSA history and other imaging, so a nuclear-medicine or oncology team should decide whether it is appropriate.

PSMA PET combines positron-emission tomography with CT or, in some centers, MRI. A radiolabeled PSMA ligand is used to visualize many prostate-cancer deposits that express prostate-specific membrane antigen. The test can help answer staging, recurrence and treatment-planning questions, but it should be ordered for a defined clinical purpose rather than as an isolated medical-tourism package.

What PSMA PET/CT can help clarify

Charité describes Ga-68 PSMA PET as a method for assessing the extent of histologically confirmed prostate cancer. Depending on the clinical situation, the scan can contribute to staging or to assessment before PSMA-targeted treatment.

Bring the records that define the clinical question

The imaging team needs context to interpret a PSMA scan meaningfully.

  • Pathology report confirming prostate cancer
  • PSA values and trend
  • Previous prostate MRI, CT, bone scan or PET imaging
  • Operative and radiotherapy reports when already treated
  • Current systemic treatment and medication
  • Recent kidney function and thyroid laboratory results when requested for contrast imaging

The visit is longer than the camera scan

Charité explains that the tracer is administered intravenously and imaging follows after an uptake period. The entire appointment can take several hours even though image acquisition itself is shorter.

PSMA positivity is also relevant before PSMA radioligand therapy

For patients being evaluated for Lu-177 PSMA therapy, Charité uses PSMA PET/CT to assess whether tumor manifestations show sufficient PSMA uptake. This does not mean that a positive scan automatically makes a patient eligible for treatment.

Ask how the result will change management

Before travelling only for imaging, clarify who requested the scan, who will interpret it, whether the images will be discussed in a multidisciplinary team and what treatment decision the result is expected to inform.

Official sources

Sources last checked 2026-08-29. Diagnostic indications and preparation requirements can change, so confirm current instructions with the imaging center before travelling.

Medical information notice: This page provides general educational information. It does not determine whether a scan is appropriate for an individual patient and should not replace specialist assessment.
Verified centers

German centers documenting this service

These are not rankings or paid recommendations. Centers are displayed alphabetically by city and are included because their official websites document the relevant treatment, diagnostic test or specialist program. Availability for an individual patient still requires clinical review.

Prostate Cancer Center Augsburg-Schwaben / Nuclear Medicine

Augsburg · The Augsburg Prostate Cancer Center explicitly lists PSMA PET-CT among its diagnostic services for detecting or differentiating prostate-cancer metastases, alongside MRI and fusion biopsy pathways.

Nuclear Medicine, University Hospital Cologne – PSMA PET/CT

Cologne · University Hospital Cologne publishes a dedicated PSMA PET/CT diagnostic pathway using Ga-68 and F-18 PSMA tracers for sensitive imaging of prostate-cancer tissue.

Nuclear Medicine, University Medicine Frankfurt

Frankfurt am Main · University Medicine Frankfurt publishes a dedicated Ga-68 PSMA PET/CT pathway for staging and recurrence assessment in prostate cancer, including patient preparation and examination workflow.

Heidelberg University Hospital Nuclear Medicine – PSMA PET/CT

Heidelberg · Heidelberg Nuclear Medicine publishes dedicated PSMA imaging with Ga-68 PSMA-11 and F-18 PSMA-1007, including patient preparation and PET/CT workflow for prostate cancer.

More verified centers4 additional centers

PET/CT Center, Saarland University Hospital

Homburg · Saarland University Hospital's PET/CT Center explicitly lists PSMA PET/CT for imaging prostate-cancer cells using a PSMA-targeted radiotracer.

Hospital profile → · Official program source ↗

Department of Nuclear Medicine, University Medical Center Leipzig

Leipzig · Leipzig's nuclear-medicine service publishes dedicated PSMA-ligand PET/CT scheduling and preparation for patients with prostate cancer.

Hospital profile → · Official program source ↗

PET/CT Center, University Medical Center Mainz

Mainz · Mainz's nuclear-medicine PET/CT center explicitly offers PSMA PET/CT for prostate cancer and accepts Ga-68 PSMA examination requests through its PET/CT pathway.

Hospital profile → · Official program source ↗

LMU Klinikum Nuclear Medicine – PSMA PET/CT

Munich · LMU Klinikum states that Ga-68 PSMA-ligand PET/CT is its standard imaging method for confirming PSMA expression before radioligand therapy and uses PSMA PET/CT within its prostate-cancer diagnostic pathway.

Hospital profile → · Official program source ↗

Browse all verified centers → · Cost guide →